Global Nucleic Acid–Based Diagnostic Market Growth (Status and Outlook) 2025-2031
According to this study, the global Nucleic Acid–Based Diagnostic market size will reach US$ million by 2031.
Nucleic acid diagnosis is a method of diagnosis of human body state and disease by using the theory and technology of molecular biology to directly investigate the existence state or defect of nucleic acid, analyze the function of nucleic acid from the nucleic acid structure, replication, transcription or translation level.Its target molecule is DNA or RNA, which reflects the structure and function of nucleic acids.The genes tested are endogenous (that is, the body's own genes) and exogenous (such as viruses, bacteria, etc.), the former is used to diagnose whether the gene has disease, the latter is used to diagnose whether there is pathogen infection.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Nucleic Acid–Based Diagnostic Industry Forecast” looks at past sales and reviews total world Nucleic Acid–Based Diagnostic sales in 2024, providing a comprehensive analysis by region and market sector of projected Nucleic Acid–Based Diagnostic sales for 2025 through 2031. With Nucleic Acid–Based Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Acid–Based Diagnostic industry.
This Insight Report provides a comprehensive analysis of the global Nucleic Acid–Based Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nucleic Acid–Based Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nucleic Acid–Based Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Acid–Based Diagnostic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Acid–Based Diagnostic.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid–Based Diagnostic market by product type, application, key players and key regions and countries.
Segmentation by Type:
Nucleic acid diagnosis is a method of diagnosis of human body state and disease by using the theory and technology of molecular biology to directly investigate the existence state or defect of nucleic acid, analyze the function of nucleic acid from the nucleic acid structure, replication, transcription or translation level.Its target molecule is DNA or RNA, which reflects the structure and function of nucleic acids.The genes tested are endogenous (that is, the body's own genes) and exogenous (such as viruses, bacteria, etc.), the former is used to diagnose whether the gene has disease, the latter is used to diagnose whether there is pathogen infection.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Nucleic Acid–Based Diagnostic Industry Forecast” looks at past sales and reviews total world Nucleic Acid–Based Diagnostic sales in 2024, providing a comprehensive analysis by region and market sector of projected Nucleic Acid–Based Diagnostic sales for 2025 through 2031. With Nucleic Acid–Based Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Acid–Based Diagnostic industry.
This Insight Report provides a comprehensive analysis of the global Nucleic Acid–Based Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nucleic Acid–Based Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nucleic Acid–Based Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Acid–Based Diagnostic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Acid–Based Diagnostic.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid–Based Diagnostic market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Nucleic Acid Molecular Hybridization
- Polymerase Chain Reaction
- Thermostatic Amplification
- Gene Sequencing
- Biochip Technology
- Hospital
- Clinical Laboratory
- Research Institutions
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Agilent Technologies
- Danaher Corporation
- Abbott Laboratories
- BD
- Bio-Rad Laboratories
- Roche
- Illumina, Inc
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Qiagen
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nucleic Acid–Based Diagnostic Market Size (2020-2031)
2.1.2 Nucleic Acid–Based Diagnostic Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Nucleic Acid–Based Diagnostic by Country/Region (2020, 2024 & 2031)
2.2 Nucleic Acid–Based Diagnostic Segment by Type
2.2.1 Nucleic Acid Molecular Hybridization
2.2.2 Polymerase Chain Reaction
2.2.3 Thermostatic Amplification
2.2.4 Gene Sequencing
2.2.5 Biochip Technology
2.3 Nucleic Acid–Based Diagnostic Market Size by Type
2.3.1 Nucleic Acid–Based Diagnostic Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2020-2025)
2.4 Nucleic Acid–Based Diagnostic Segment by Application
2.4.1 Hospital
2.4.2 Clinical Laboratory
2.4.3 Research Institutions
2.4.4 Clinic
2.4.5 Other
2.5 Nucleic Acid–Based Diagnostic Market Size by Application
2.5.1 Nucleic Acid–Based Diagnostic Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2020-2025)
3 NUCLEIC ACID–BASED DIAGNOSTIC MARKET SIZE BY PLAYER
3.1 Nucleic Acid–Based Diagnostic Market Size Market Share by Player
3.1.1 Global Nucleic Acid–Based Diagnostic Revenue by Player (2020-2025)
3.1.2 Global Nucleic Acid–Based Diagnostic Revenue Market Share by Player (2020-2025)
3.2 Global Nucleic Acid–Based Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEIC ACID–BASED DIAGNOSTIC BY REGION
4.1 Nucleic Acid–Based Diagnostic Market Size by Region (2020-2025)
4.2 Global Nucleic Acid–Based Diagnostic Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nucleic Acid–Based Diagnostic Market Size Growth (2020-2025)
4.4 APAC Nucleic Acid–Based Diagnostic Market Size Growth (2020-2025)
4.5 Europe Nucleic Acid–Based Diagnostic Market Size Growth (2020-2025)
4.6 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Nucleic Acid–Based Diagnostic Market Size by Country (2020-2025)
5.2 Americas Nucleic Acid–Based Diagnostic Market Size by Type (2020-2025)
5.3 Americas Nucleic Acid–Based Diagnostic Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid–Based Diagnostic Market Size by Region (2020-2025)
6.2 APAC Nucleic Acid–Based Diagnostic Market Size by Type (2020-2025)
6.3 APAC Nucleic Acid–Based Diagnostic Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nucleic Acid–Based Diagnostic Market Size by Country (2020-2025)
7.2 Europe Nucleic Acid–Based Diagnostic Market Size by Type (2020-2025)
7.3 Europe Nucleic Acid–Based Diagnostic Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nucleic Acid–Based Diagnostic by Region (2020-2025)
8.2 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Type (2020-2025)
8.3 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEIC ACID–BASED DIAGNOSTIC MARKET FORECAST
10.1 Global Nucleic Acid–Based Diagnostic Forecast by Region (2026-2031)
10.1.1 Global Nucleic Acid–Based Diagnostic Forecast by Region (2026-2031)
10.1.2 Americas Nucleic Acid–Based Diagnostic Forecast
10.1.3 APAC Nucleic Acid–Based Diagnostic Forecast
10.1.4 Europe Nucleic Acid–Based Diagnostic Forecast
10.1.5 Middle East & Africa Nucleic Acid–Based Diagnostic Forecast
10.2 Americas Nucleic Acid–Based Diagnostic Forecast by Country (2026-2031)
10.2.1 United States Market Nucleic Acid–Based Diagnostic Forecast
10.2.2 Canada Market Nucleic Acid–Based Diagnostic Forecast
10.2.3 Mexico Market Nucleic Acid–Based Diagnostic Forecast
10.2.4 Brazil Market Nucleic Acid–Based Diagnostic Forecast
10.3 APAC Nucleic Acid–Based Diagnostic Forecast by Region (2026-2031)
10.3.1 China Nucleic Acid–Based Diagnostic Market Forecast
10.3.2 Japan Market Nucleic Acid–Based Diagnostic Forecast
10.3.3 Korea Market Nucleic Acid–Based Diagnostic Forecast
10.3.4 Southeast Asia Market Nucleic Acid–Based Diagnostic Forecast
10.3.5 India Market Nucleic Acid–Based Diagnostic Forecast
10.3.6 Australia Market Nucleic Acid–Based Diagnostic Forecast
10.4 Europe Nucleic Acid–Based Diagnostic Forecast by Country (2026-2031)
10.4.1 Germany Market Nucleic Acid–Based Diagnostic Forecast
10.4.2 France Market Nucleic Acid–Based Diagnostic Forecast
10.4.3 UK Market Nucleic Acid–Based Diagnostic Forecast
10.4.4 Italy Market Nucleic Acid–Based Diagnostic Forecast
10.4.5 Russia Market Nucleic Acid–Based Diagnostic Forecast
10.5 Middle East & Africa Nucleic Acid–Based Diagnostic Forecast by Region (2026-2031)
10.5.1 Egypt Market Nucleic Acid–Based Diagnostic Forecast
10.5.2 South Africa Market Nucleic Acid–Based Diagnostic Forecast
10.5.3 Israel Market Nucleic Acid–Based Diagnostic Forecast
10.5.4 Turkey Market Nucleic Acid–Based Diagnostic Forecast
10.6 Global Nucleic Acid–Based Diagnostic Forecast by Type (2026-2031)
10.7 Global Nucleic Acid–Based Diagnostic Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Nucleic Acid–Based Diagnostic Forecast
11 KEY PLAYERS ANALYSIS
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Information
11.1.2 Agilent Technologies Nucleic Acid–Based Diagnostic Product Offered
11.1.3 Agilent Technologies Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Agilent Technologies Main Business Overview
11.1.5 Agilent Technologies Latest Developments
11.2 Danaher Corporation
11.2.1 Danaher Corporation Company Information
11.2.2 Danaher Corporation Nucleic Acid–Based Diagnostic Product Offered
11.2.3 Danaher Corporation Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Danaher Corporation Main Business Overview
11.2.5 Danaher Corporation Latest Developments
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Information
11.3.2 Abbott Laboratories Nucleic Acid–Based Diagnostic Product Offered
11.3.3 Abbott Laboratories Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Abbott Laboratories Main Business Overview
11.3.5 Abbott Laboratories Latest Developments
11.4 BD
11.4.1 BD Company Information
11.4.2 BD Nucleic Acid–Based Diagnostic Product Offered
11.4.3 BD Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 BD Main Business Overview
11.4.5 BD Latest Developments
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Information
11.5.2 Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Product Offered
11.5.3 Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Bio-Rad Laboratories Main Business Overview
11.5.5 Bio-Rad Laboratories Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Nucleic Acid–Based Diagnostic Product Offered
11.6.3 Roche Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 Illumina, Inc
11.7.1 Illumina, Inc Company Information
11.7.2 Illumina, Inc Nucleic Acid–Based Diagnostic Product Offered
11.7.3 Illumina, Inc Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Illumina, Inc Main Business Overview
11.7.5 Illumina, Inc Latest Developments
11.8 Thermo Fisher Scientific Inc.
11.8.1 Thermo Fisher Scientific Inc. Company Information
11.8.2 Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Product Offered
11.8.3 Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Thermo Fisher Scientific Inc. Main Business Overview
11.8.5 Thermo Fisher Scientific Inc. Latest Developments
11.9 Merck KGaA
11.9.1 Merck KGaA Company Information
11.9.2 Merck KGaA Nucleic Acid–Based Diagnostic Product Offered
11.9.3 Merck KGaA Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Merck KGaA Main Business Overview
11.9.5 Merck KGaA Latest Developments
11.10 Qiagen
11.10.1 Qiagen Company Information
11.10.2 Qiagen Nucleic Acid–Based Diagnostic Product Offered
11.10.3 Qiagen Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Qiagen Main Business Overview
11.10.5 Qiagen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nucleic Acid–Based Diagnostic Market Size (2020-2031)
2.1.2 Nucleic Acid–Based Diagnostic Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Nucleic Acid–Based Diagnostic by Country/Region (2020, 2024 & 2031)
2.2 Nucleic Acid–Based Diagnostic Segment by Type
2.2.1 Nucleic Acid Molecular Hybridization
2.2.2 Polymerase Chain Reaction
2.2.3 Thermostatic Amplification
2.2.4 Gene Sequencing
2.2.5 Biochip Technology
2.3 Nucleic Acid–Based Diagnostic Market Size by Type
2.3.1 Nucleic Acid–Based Diagnostic Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2020-2025)
2.4 Nucleic Acid–Based Diagnostic Segment by Application
2.4.1 Hospital
2.4.2 Clinical Laboratory
2.4.3 Research Institutions
2.4.4 Clinic
2.4.5 Other
2.5 Nucleic Acid–Based Diagnostic Market Size by Application
2.5.1 Nucleic Acid–Based Diagnostic Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2020-2025)
3 NUCLEIC ACID–BASED DIAGNOSTIC MARKET SIZE BY PLAYER
3.1 Nucleic Acid–Based Diagnostic Market Size Market Share by Player
3.1.1 Global Nucleic Acid–Based Diagnostic Revenue by Player (2020-2025)
3.1.2 Global Nucleic Acid–Based Diagnostic Revenue Market Share by Player (2020-2025)
3.2 Global Nucleic Acid–Based Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEIC ACID–BASED DIAGNOSTIC BY REGION
4.1 Nucleic Acid–Based Diagnostic Market Size by Region (2020-2025)
4.2 Global Nucleic Acid–Based Diagnostic Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nucleic Acid–Based Diagnostic Market Size Growth (2020-2025)
4.4 APAC Nucleic Acid–Based Diagnostic Market Size Growth (2020-2025)
4.5 Europe Nucleic Acid–Based Diagnostic Market Size Growth (2020-2025)
4.6 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Nucleic Acid–Based Diagnostic Market Size by Country (2020-2025)
5.2 Americas Nucleic Acid–Based Diagnostic Market Size by Type (2020-2025)
5.3 Americas Nucleic Acid–Based Diagnostic Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid–Based Diagnostic Market Size by Region (2020-2025)
6.2 APAC Nucleic Acid–Based Diagnostic Market Size by Type (2020-2025)
6.3 APAC Nucleic Acid–Based Diagnostic Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nucleic Acid–Based Diagnostic Market Size by Country (2020-2025)
7.2 Europe Nucleic Acid–Based Diagnostic Market Size by Type (2020-2025)
7.3 Europe Nucleic Acid–Based Diagnostic Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nucleic Acid–Based Diagnostic by Region (2020-2025)
8.2 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Type (2020-2025)
8.3 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEIC ACID–BASED DIAGNOSTIC MARKET FORECAST
10.1 Global Nucleic Acid–Based Diagnostic Forecast by Region (2026-2031)
10.1.1 Global Nucleic Acid–Based Diagnostic Forecast by Region (2026-2031)
10.1.2 Americas Nucleic Acid–Based Diagnostic Forecast
10.1.3 APAC Nucleic Acid–Based Diagnostic Forecast
10.1.4 Europe Nucleic Acid–Based Diagnostic Forecast
10.1.5 Middle East & Africa Nucleic Acid–Based Diagnostic Forecast
10.2 Americas Nucleic Acid–Based Diagnostic Forecast by Country (2026-2031)
10.2.1 United States Market Nucleic Acid–Based Diagnostic Forecast
10.2.2 Canada Market Nucleic Acid–Based Diagnostic Forecast
10.2.3 Mexico Market Nucleic Acid–Based Diagnostic Forecast
10.2.4 Brazil Market Nucleic Acid–Based Diagnostic Forecast
10.3 APAC Nucleic Acid–Based Diagnostic Forecast by Region (2026-2031)
10.3.1 China Nucleic Acid–Based Diagnostic Market Forecast
10.3.2 Japan Market Nucleic Acid–Based Diagnostic Forecast
10.3.3 Korea Market Nucleic Acid–Based Diagnostic Forecast
10.3.4 Southeast Asia Market Nucleic Acid–Based Diagnostic Forecast
10.3.5 India Market Nucleic Acid–Based Diagnostic Forecast
10.3.6 Australia Market Nucleic Acid–Based Diagnostic Forecast
10.4 Europe Nucleic Acid–Based Diagnostic Forecast by Country (2026-2031)
10.4.1 Germany Market Nucleic Acid–Based Diagnostic Forecast
10.4.2 France Market Nucleic Acid–Based Diagnostic Forecast
10.4.3 UK Market Nucleic Acid–Based Diagnostic Forecast
10.4.4 Italy Market Nucleic Acid–Based Diagnostic Forecast
10.4.5 Russia Market Nucleic Acid–Based Diagnostic Forecast
10.5 Middle East & Africa Nucleic Acid–Based Diagnostic Forecast by Region (2026-2031)
10.5.1 Egypt Market Nucleic Acid–Based Diagnostic Forecast
10.5.2 South Africa Market Nucleic Acid–Based Diagnostic Forecast
10.5.3 Israel Market Nucleic Acid–Based Diagnostic Forecast
10.5.4 Turkey Market Nucleic Acid–Based Diagnostic Forecast
10.6 Global Nucleic Acid–Based Diagnostic Forecast by Type (2026-2031)
10.7 Global Nucleic Acid–Based Diagnostic Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Nucleic Acid–Based Diagnostic Forecast
11 KEY PLAYERS ANALYSIS
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Information
11.1.2 Agilent Technologies Nucleic Acid–Based Diagnostic Product Offered
11.1.3 Agilent Technologies Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Agilent Technologies Main Business Overview
11.1.5 Agilent Technologies Latest Developments
11.2 Danaher Corporation
11.2.1 Danaher Corporation Company Information
11.2.2 Danaher Corporation Nucleic Acid–Based Diagnostic Product Offered
11.2.3 Danaher Corporation Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Danaher Corporation Main Business Overview
11.2.5 Danaher Corporation Latest Developments
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Information
11.3.2 Abbott Laboratories Nucleic Acid–Based Diagnostic Product Offered
11.3.3 Abbott Laboratories Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Abbott Laboratories Main Business Overview
11.3.5 Abbott Laboratories Latest Developments
11.4 BD
11.4.1 BD Company Information
11.4.2 BD Nucleic Acid–Based Diagnostic Product Offered
11.4.3 BD Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 BD Main Business Overview
11.4.5 BD Latest Developments
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Information
11.5.2 Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Product Offered
11.5.3 Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Bio-Rad Laboratories Main Business Overview
11.5.5 Bio-Rad Laboratories Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Nucleic Acid–Based Diagnostic Product Offered
11.6.3 Roche Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 Illumina, Inc
11.7.1 Illumina, Inc Company Information
11.7.2 Illumina, Inc Nucleic Acid–Based Diagnostic Product Offered
11.7.3 Illumina, Inc Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Illumina, Inc Main Business Overview
11.7.5 Illumina, Inc Latest Developments
11.8 Thermo Fisher Scientific Inc.
11.8.1 Thermo Fisher Scientific Inc. Company Information
11.8.2 Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Product Offered
11.8.3 Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Thermo Fisher Scientific Inc. Main Business Overview
11.8.5 Thermo Fisher Scientific Inc. Latest Developments
11.9 Merck KGaA
11.9.1 Merck KGaA Company Information
11.9.2 Merck KGaA Nucleic Acid–Based Diagnostic Product Offered
11.9.3 Merck KGaA Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Merck KGaA Main Business Overview
11.9.5 Merck KGaA Latest Developments
11.10 Qiagen
11.10.1 Qiagen Company Information
11.10.2 Qiagen Nucleic Acid–Based Diagnostic Product Offered
11.10.3 Qiagen Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Qiagen Main Business Overview
11.10.5 Qiagen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nucleic Acid–Based Diagnostic Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Nucleic Acid–Based Diagnostic Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Nucleic Acid Molecular Hybridization
Table 4. Major Players of Polymerase Chain Reaction
Table 5. Major Players of Thermostatic Amplification
Table 6. Major Players of Gene Sequencing
Table 7. Major Players of Biochip Technology
Table 8. Nucleic Acid–Based Diagnostic Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Nucleic Acid–Based Diagnostic Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2020-2025)
Table 11. Nucleic Acid–Based Diagnostic Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Nucleic Acid–Based Diagnostic Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2020-2025)
Table 14. Global Nucleic Acid–Based Diagnostic Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Player (2020-2025)
Table 16. Nucleic Acid–Based Diagnostic Key Players Head office and Products Offered
Table 17. Nucleic Acid–Based Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Nucleic Acid–Based Diagnostic Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Region (2020-2025)
Table 22. Global Nucleic Acid–Based Diagnostic Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Nucleic Acid–Based Diagnostic Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Nucleic Acid–Based Diagnostic Market Size Market Share by Country (2020-2025)
Table 26. Americas Nucleic Acid–Based Diagnostic Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2020-2025)
Table 28. Americas Nucleic Acid–Based Diagnostic Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2020-2025)
Table 30. APAC Nucleic Acid–Based Diagnostic Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Nucleic Acid–Based Diagnostic Market Size Market Share by Region (2020-2025)
Table 32. APAC Nucleic Acid–Based Diagnostic Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Nucleic Acid–Based Diagnostic Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Nucleic Acid–Based Diagnostic Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Nucleic Acid–Based Diagnostic Market Size Market Share by Country (2020-2025)
Table 36. Europe Nucleic Acid–Based Diagnostic Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Nucleic Acid–Based Diagnostic Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Nucleic Acid–Based Diagnostic
Table 42. Key Market Challenges & Risks of Nucleic Acid–Based Diagnostic
Table 43. Key Industry Trends of Nucleic Acid–Based Diagnostic
Table 44. Global Nucleic Acid–Based Diagnostic Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Nucleic Acid–Based Diagnostic Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Nucleic Acid–Based Diagnostic Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Nucleic Acid–Based Diagnostic Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Agilent Technologies Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 49. Agilent Technologies Nucleic Acid–Based Diagnostic Product Offered
Table 50. Agilent Technologies Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Agilent Technologies Main Business
Table 52. Agilent Technologies Latest Developments
Table 53. Danaher Corporation Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 54. Danaher Corporation Nucleic Acid–Based Diagnostic Product Offered
Table 55. Danaher Corporation Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Danaher Corporation Main Business
Table 57. Danaher Corporation Latest Developments
Table 58. Abbott Laboratories Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 59. Abbott Laboratories Nucleic Acid–Based Diagnostic Product Offered
Table 60. Abbott Laboratories Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Abbott Laboratories Main Business
Table 62. Abbott Laboratories Latest Developments
Table 63. BD Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 64. BD Nucleic Acid–Based Diagnostic Product Offered
Table 65. BD Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. BD Main Business
Table 67. BD Latest Developments
Table 68. Bio-Rad Laboratories Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 69. Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Product Offered
Table 70. Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Bio-Rad Laboratories Main Business
Table 72. Bio-Rad Laboratories Latest Developments
Table 73. Roche Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 74. Roche Nucleic Acid–Based Diagnostic Product Offered
Table 75. Roche Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Roche Main Business
Table 77. Roche Latest Developments
Table 78. Illumina, Inc Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 79. Illumina, Inc Nucleic Acid–Based Diagnostic Product Offered
Table 80. Illumina, Inc Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Illumina, Inc Main Business
Table 82. Illumina, Inc Latest Developments
Table 83. Thermo Fisher Scientific Inc. Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 84. Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Product Offered
Table 85. Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Thermo Fisher Scientific Inc. Main Business
Table 87. Thermo Fisher Scientific Inc. Latest Developments
Table 88. Merck KGaA Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 89. Merck KGaA Nucleic Acid–Based Diagnostic Product Offered
Table 90. Merck KGaA Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Merck KGaA Main Business
Table 92. Merck KGaA Latest Developments
Table 93. Qiagen Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 94. Qiagen Nucleic Acid–Based Diagnostic Product Offered
Table 95. Qiagen Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Qiagen Main Business
Table 97. Qiagen Latest Developments
Table 1. Nucleic Acid–Based Diagnostic Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Nucleic Acid–Based Diagnostic Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Nucleic Acid Molecular Hybridization
Table 4. Major Players of Polymerase Chain Reaction
Table 5. Major Players of Thermostatic Amplification
Table 6. Major Players of Gene Sequencing
Table 7. Major Players of Biochip Technology
Table 8. Nucleic Acid–Based Diagnostic Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Nucleic Acid–Based Diagnostic Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2020-2025)
Table 11. Nucleic Acid–Based Diagnostic Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Nucleic Acid–Based Diagnostic Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2020-2025)
Table 14. Global Nucleic Acid–Based Diagnostic Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Player (2020-2025)
Table 16. Nucleic Acid–Based Diagnostic Key Players Head office and Products Offered
Table 17. Nucleic Acid–Based Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Nucleic Acid–Based Diagnostic Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Region (2020-2025)
Table 22. Global Nucleic Acid–Based Diagnostic Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Nucleic Acid–Based Diagnostic Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Nucleic Acid–Based Diagnostic Market Size Market Share by Country (2020-2025)
Table 26. Americas Nucleic Acid–Based Diagnostic Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2020-2025)
Table 28. Americas Nucleic Acid–Based Diagnostic Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2020-2025)
Table 30. APAC Nucleic Acid–Based Diagnostic Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Nucleic Acid–Based Diagnostic Market Size Market Share by Region (2020-2025)
Table 32. APAC Nucleic Acid–Based Diagnostic Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Nucleic Acid–Based Diagnostic Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Nucleic Acid–Based Diagnostic Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Nucleic Acid–Based Diagnostic Market Size Market Share by Country (2020-2025)
Table 36. Europe Nucleic Acid–Based Diagnostic Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Nucleic Acid–Based Diagnostic Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Nucleic Acid–Based Diagnostic
Table 42. Key Market Challenges & Risks of Nucleic Acid–Based Diagnostic
Table 43. Key Industry Trends of Nucleic Acid–Based Diagnostic
Table 44. Global Nucleic Acid–Based Diagnostic Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Nucleic Acid–Based Diagnostic Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Nucleic Acid–Based Diagnostic Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Nucleic Acid–Based Diagnostic Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Agilent Technologies Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 49. Agilent Technologies Nucleic Acid–Based Diagnostic Product Offered
Table 50. Agilent Technologies Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Agilent Technologies Main Business
Table 52. Agilent Technologies Latest Developments
Table 53. Danaher Corporation Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 54. Danaher Corporation Nucleic Acid–Based Diagnostic Product Offered
Table 55. Danaher Corporation Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Danaher Corporation Main Business
Table 57. Danaher Corporation Latest Developments
Table 58. Abbott Laboratories Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 59. Abbott Laboratories Nucleic Acid–Based Diagnostic Product Offered
Table 60. Abbott Laboratories Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Abbott Laboratories Main Business
Table 62. Abbott Laboratories Latest Developments
Table 63. BD Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 64. BD Nucleic Acid–Based Diagnostic Product Offered
Table 65. BD Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. BD Main Business
Table 67. BD Latest Developments
Table 68. Bio-Rad Laboratories Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 69. Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Product Offered
Table 70. Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Bio-Rad Laboratories Main Business
Table 72. Bio-Rad Laboratories Latest Developments
Table 73. Roche Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 74. Roche Nucleic Acid–Based Diagnostic Product Offered
Table 75. Roche Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Roche Main Business
Table 77. Roche Latest Developments
Table 78. Illumina, Inc Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 79. Illumina, Inc Nucleic Acid–Based Diagnostic Product Offered
Table 80. Illumina, Inc Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Illumina, Inc Main Business
Table 82. Illumina, Inc Latest Developments
Table 83. Thermo Fisher Scientific Inc. Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 84. Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Product Offered
Table 85. Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Thermo Fisher Scientific Inc. Main Business
Table 87. Thermo Fisher Scientific Inc. Latest Developments
Table 88. Merck KGaA Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 89. Merck KGaA Nucleic Acid–Based Diagnostic Product Offered
Table 90. Merck KGaA Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Merck KGaA Main Business
Table 92. Merck KGaA Latest Developments
Table 93. Qiagen Details, Company Type, Nucleic Acid–Based Diagnostic Area Served and Its Competitors
Table 94. Qiagen Nucleic Acid–Based Diagnostic Product Offered
Table 95. Qiagen Nucleic Acid–Based Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Qiagen Main Business
Table 97. Qiagen Latest Developments
LIST OF FIGURES
Figure 1. Nucleic Acid–Based Diagnostic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nucleic Acid–Based Diagnostic Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Nucleic Acid–Based Diagnostic Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Nucleic Acid–Based Diagnostic Sales Market Share by Country/Region (2024)
Figure 8. Nucleic Acid–Based Diagnostic Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Type in 2024
Figure 10. Nucleic Acid–Based Diagnostic in Hospital
Figure 11. Global Nucleic Acid–Based Diagnostic Market: Hospital (2020-2025) & ($ millions)
Figure 12. Nucleic Acid–Based Diagnostic in Clinical Laboratory
Figure 13. Global Nucleic Acid–Based Diagnostic Market: Clinical Laboratory (2020-2025) & ($ millions)
Figure 14. Nucleic Acid–Based Diagnostic in Research Institutions
Figure 15. Global Nucleic Acid–Based Diagnostic Market: Research Institutions (2020-2025) & ($ millions)
Figure 16. Nucleic Acid–Based Diagnostic in Clinic
Figure 17. Global Nucleic Acid–Based Diagnostic Market: Clinic (2020-2025) & ($ millions)
Figure 18. Nucleic Acid–Based Diagnostic in Other
Figure 19. Global Nucleic Acid–Based Diagnostic Market: Other (2020-2025) & ($ millions)
Figure 20. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Application in 2024
Figure 21. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Player in 2024
Figure 22. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Region (2020-2025)
Figure 23. Americas Nucleic Acid–Based Diagnostic Market Size 2020-2025 ($ millions)
Figure 24. APAC Nucleic Acid–Based Diagnostic Market Size 2020-2025 ($ millions)
Figure 25. Europe Nucleic Acid–Based Diagnostic Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size 2020-2025 ($ millions)
Figure 27. Americas Nucleic Acid–Based Diagnostic Value Market Share by Country in 2024
Figure 28. United States Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Nucleic Acid–Based Diagnostic Market Size Market Share by Region in 2024
Figure 33. APAC Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2020-2025)
Figure 34. APAC Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2020-2025)
Figure 35. China Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 39. India Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Nucleic Acid–Based Diagnostic Market Size Market Share by Country in 2024
Figure 42. Europe Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2020-2025)
Figure 43. Europe Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2020-2025)
Figure 44. Germany Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 45. France Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 58. APAC Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 59. Europe Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 61. United States Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 62. Canada Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 63. Mexico Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 64. Brazil Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 65. China Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 66. Japan Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 67. Korea Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 69. India Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 70. Australia Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 71. Germany Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 72. France Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 73. UK Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 74. Italy Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 75. Russia Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 76. Egypt Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 77. South Africa Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 78. Israel Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 79. Turkey Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 80. Global Nucleic Acid–Based Diagnostic Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Nucleic Acid–Based Diagnostic Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 1. Nucleic Acid–Based Diagnostic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nucleic Acid–Based Diagnostic Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Nucleic Acid–Based Diagnostic Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Nucleic Acid–Based Diagnostic Sales Market Share by Country/Region (2024)
Figure 8. Nucleic Acid–Based Diagnostic Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Type in 2024
Figure 10. Nucleic Acid–Based Diagnostic in Hospital
Figure 11. Global Nucleic Acid–Based Diagnostic Market: Hospital (2020-2025) & ($ millions)
Figure 12. Nucleic Acid–Based Diagnostic in Clinical Laboratory
Figure 13. Global Nucleic Acid–Based Diagnostic Market: Clinical Laboratory (2020-2025) & ($ millions)
Figure 14. Nucleic Acid–Based Diagnostic in Research Institutions
Figure 15. Global Nucleic Acid–Based Diagnostic Market: Research Institutions (2020-2025) & ($ millions)
Figure 16. Nucleic Acid–Based Diagnostic in Clinic
Figure 17. Global Nucleic Acid–Based Diagnostic Market: Clinic (2020-2025) & ($ millions)
Figure 18. Nucleic Acid–Based Diagnostic in Other
Figure 19. Global Nucleic Acid–Based Diagnostic Market: Other (2020-2025) & ($ millions)
Figure 20. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Application in 2024
Figure 21. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Player in 2024
Figure 22. Global Nucleic Acid–Based Diagnostic Market Size Market Share by Region (2020-2025)
Figure 23. Americas Nucleic Acid–Based Diagnostic Market Size 2020-2025 ($ millions)
Figure 24. APAC Nucleic Acid–Based Diagnostic Market Size 2020-2025 ($ millions)
Figure 25. Europe Nucleic Acid–Based Diagnostic Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size 2020-2025 ($ millions)
Figure 27. Americas Nucleic Acid–Based Diagnostic Value Market Share by Country in 2024
Figure 28. United States Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Nucleic Acid–Based Diagnostic Market Size Market Share by Region in 2024
Figure 33. APAC Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2020-2025)
Figure 34. APAC Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2020-2025)
Figure 35. China Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 39. India Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Nucleic Acid–Based Diagnostic Market Size Market Share by Country in 2024
Figure 42. Europe Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2020-2025)
Figure 43. Europe Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2020-2025)
Figure 44. Germany Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 45. France Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Nucleic Acid–Based Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 58. APAC Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 59. Europe Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 61. United States Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 62. Canada Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 63. Mexico Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 64. Brazil Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 65. China Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 66. Japan Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 67. Korea Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 69. India Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 70. Australia Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 71. Germany Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 72. France Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 73. UK Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 74. Italy Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 75. Russia Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 76. Egypt Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 77. South Africa Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 78. Israel Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 79. Turkey Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
Figure 80. Global Nucleic Acid–Based Diagnostic Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Nucleic Acid–Based Diagnostic Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Nucleic Acid–Based Diagnostic Market Size 2026-2031 ($ millions)
More Publications
Global Medical Electronic Thermometer Market Growth 2025-2031
US$ 3,660.00
April 2025
182 pages
Global Surgical Caps Market Growth 2024-2030
US$ 3,660.00
December 2024
134 pages
Global Travelers Vaccines Market Growth 2026-2032
US$ 3,660.00
June 2026
116 pages
Global Medical Cyclotron Market Growth 2025-2031
US$ 3,660.00
March 2025
104 pages
Global Pantoprazole Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
176 pages
